Loading candles…
Venus Remedies Ltd, incorporated in 1989, is a research-based pharmaceutical company operating in the pharmaceutical and healthcare industries. The company focuses on developing and manufacturing therapeutic solutions primarily within critical care segments, including treatments for multi-drug resistant bacteria. Its product portfolio spans anti-infectives such as antibiotics, oncology, neurology, pain management, and skin and wound care. Venus Remedies serves both domestic and international markets through its manufacturing facilities. The company includes the Venus Medicine Research Centre (VMRC), its research division accredited by the Department of Scientific and Industrial Research (DSIR). No information on founders, key management, listings, or notable projects was provided.
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 1 Aug 2025 |
| Other | To consider other business ma1. To consider and approve Notice of 36th Annual General Meeting.2. To consider and approve Board s Report for Financial Year 20… | 8 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 26 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.